Selected research
Industry Research
Prilocaine Industry Research Report 2026
Market perspective
The global Prilocaine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Prilocaine is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Prilocaine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Prilocaine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Prilocaine include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Prilocaine market in revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Prilocaine.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Prilocaine Market by Company
Active Biopharma Corp
Anant Pharmaceuticals
B. Braun
ANXIN PHARMACEUTICAL
Yeasen Biotechnology
Nanjing HuaNuo Bio-Pharmaceutical Technology
Beijing Vokai Biotechnology
Haisco Pharmaceutical Group
Prilocaine Segment by Type
3% Solution
2% Solution
1% Solution
Other
Prilocaine Segment by Application
Public Hospital
Private Hospital
Prilocaine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prilocaine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prilocaine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prilocaine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Prilocaine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Prilocaine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Prilocaine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 3% Solution
- 2% Solution
- 1% Solution
- Other
Applications
- Public Hospital
- Private Hospital
Companies covered
- Active Biopharma Corp
- Anant Pharmaceuticals
- B. Braun
- ANXIN PHARMACEUTICAL
- Yeasen Biotechnology
- Nanjing HuaNuo Bio-Pharmaceutical Technology
- Beijing Vokai Biotechnology
- Haisco Pharmaceutical Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Prilocaine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 3% Solution
- 2.2.3 2% Solution
- 2.2.4 1% Solution
- 2.2.5 Other
- 2.3 Prilocaine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Public Hospital
- 2.3.3 Private Hospital
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Prilocaine Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Prilocaine Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Prilocaine Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Prilocaine Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Prilocaine Production by Manufacturers (2021-2026)
- 3.2 Global Prilocaine Production Value by Manufacturers (2021-2026)
- 3.3 Global Prilocaine Average Price by Manufacturers (2021-2026)
- 3.4 Global Prilocaine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Prilocaine Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Prilocaine Manufacturers, Product Type & Application
- 3.7 Global Prilocaine Manufacturers Established Date
- 3.8 Global Prilocaine Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Active Biopharma Corp
- 4.1.1 Active Biopharma Corp Prilocaine Company Information
- 4.1.2 Active Biopharma Corp Prilocaine Business Overview
- 4.1.3 Active Biopharma Corp Prilocaine Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Active Biopharma Corp Product Portfolio
- 4.1.5 Active Biopharma Corp Recent Developments
- 4.2 Anant Pharmaceuticals
- 4.2.1 Anant Pharmaceuticals Prilocaine Company Information
- 4.2.2 Anant Pharmaceuticals Prilocaine Business Overview
- 4.2.3 Anant Pharmaceuticals Prilocaine Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Anant Pharmaceuticals Product Portfolio
- 4.2.5 Anant Pharmaceuticals Recent Developments
- 4.3 B. Braun
- 4.3.1 B. Braun Prilocaine Company Information
- 4.3.2 B. Braun Prilocaine Business Overview
- 4.3.3 B. Braun Prilocaine Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 B. Braun Product Portfolio
- 4.3.5 B. Braun Recent Developments
- 4.4 ANXIN PHARMACEUTICAL
- 4.4.1 ANXIN PHARMACEUTICAL Prilocaine Company Information
- 4.4.2 ANXIN PHARMACEUTICAL Prilocaine Business Overview
- 4.4.3 ANXIN PHARMACEUTICAL Prilocaine Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 ANXIN PHARMACEUTICAL Product Portfolio
- 4.4.5 ANXIN PHARMACEUTICAL Recent Developments
- 4.5 Yeasen Biotechnology
- 4.5.1 Yeasen Biotechnology Prilocaine Company Information
- 4.5.2 Yeasen Biotechnology Prilocaine Business Overview
- 4.5.3 Yeasen Biotechnology Prilocaine Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Yeasen Biotechnology Product Portfolio
- 4.5.5 Yeasen Biotechnology Recent Developments
- 4.6 Nanjing HuaNuo Bio-Pharmaceutical Technology
- 4.6.1 Nanjing HuaNuo Bio-Pharmaceutical Technology Prilocaine Company Information
- 4.6.2 Nanjing HuaNuo Bio-Pharmaceutical Technology Prilocaine Business Overview
- 4.6.3 Nanjing HuaNuo Bio-Pharmaceutical Technology Prilocaine Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Nanjing HuaNuo Bio-Pharmaceutical Technology Product Portfolio
- 4.6.5 Nanjing HuaNuo Bio-Pharmaceutical Technology Recent Developments
- 4.7 Beijing Vokai Biotechnology
- 4.7.1 Beijing Vokai Biotechnology Prilocaine Company Information
- 4.7.2 Beijing Vokai Biotechnology Prilocaine Business Overview
- 4.7.3 Beijing Vokai Biotechnology Prilocaine Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Beijing Vokai Biotechnology Product Portfolio
- 4.7.5 Beijing Vokai Biotechnology Recent Developments
- 4.8 Haisco Pharmaceutical Group
- 4.8.1 Haisco Pharmaceutical Group Prilocaine Company Information
- 4.8.2 Haisco Pharmaceutical Group Prilocaine Business Overview
- 4.8.3 Haisco Pharmaceutical Group Prilocaine Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Haisco Pharmaceutical Group Product Portfolio
- 4.8.5 Haisco Pharmaceutical Group Recent Developments
5 Global Prilocaine Production by Region
- 5.1 Global Prilocaine Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Prilocaine Production by Region: 2021-2032
- 5.2.1 Global Prilocaine Production by Region: 2021-2026
- 5.2.2 Global Prilocaine Production Forecast by Region (2027-2032)
- 5.3 Global Prilocaine Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Prilocaine Production Value by Region: 2021-2032
- 5.4.1 Global Prilocaine Production Value by Region: 2021-2026
- 5.4.2 Global Prilocaine Production Value Forecast by Region (2027-2032)
- 5.5 Global Prilocaine Market Price Analysis by Region (2021-2026)
- 5.6 Global Prilocaine Production and Value, YOY Growth
- 5.6.1 North America Prilocaine Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Prilocaine Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Prilocaine Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Prilocaine Production Value Estimates and Forecasts (2021-2032)
6 Global Prilocaine Consumption by Region
- 6.1 Global Prilocaine Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Prilocaine Consumption by Region (2021-2032)
- 6.2.1 Global Prilocaine Consumption by Region: 2021-2026
- 6.2.2 Global Prilocaine Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Prilocaine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Prilocaine Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Prilocaine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Prilocaine Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Prilocaine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Prilocaine Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Prilocaine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Prilocaine Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Prilocaine Production by Type (2021-2032)
- 7.1.1 Global Prilocaine Production by Type (2021-2032) & (Kg)
- 7.1.2 Global Prilocaine Production Market Share by Type (2021-2032)
- 7.2 Global Prilocaine Production Value by Type (2021-2032)
- 7.2.1 Global Prilocaine Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Prilocaine Production Value Market Share by Type (2021-2032)
- 7.3 Global Prilocaine Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Prilocaine Production by Application (2021-2032)
- 8.1.1 Global Prilocaine Production by Application (2021-2032) & (Kg)
- 8.1.2 Global Prilocaine Production Market Share by Application (2021-2032)
- 8.2 Global Prilocaine Production Value by Application (2021-2032)
- 8.2.1 Global Prilocaine Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Prilocaine Production Value Market Share by Application (2021-2032)
- 8.3 Global Prilocaine Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Prilocaine Value Chain Analysis
- 9.1.1 Prilocaine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Prilocaine Production Mode & Process
- 9.2 Prilocaine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Prilocaine Distributors
- 9.2.3 Prilocaine Customers
10 Global Prilocaine Analyzing Market Dynamics
- 10.1 Prilocaine Industry Trends
- 10.2 Prilocaine Industry Drivers
- 10.3 Prilocaine Industry Opportunities and Challenges
- 10.4 Prilocaine Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst